These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 2942387)

  • 21. [Hypokalemia, hypomagnesemia and ventricular arrhythmia during diuretic treatment of arterial hypertension].
    Hannedouche T; Delgado A
    Arch Mal Coeur Vaiss; 1988 Jun; 81(6):819-24. PubMed ID: 3144955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Revival of antihypertensive therapy: use of thiazide diuretics].
    Nagy V
    Orv Hetil; 2004 Mar; 145(13):669-76. PubMed ID: 15125317
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diuretics, arrhythmias and silent myocardial ischaemia in hypertensive patients.
    Storstein L
    Eur Heart J; 1992 Dec; 13 Suppl G():81-4. PubMed ID: 1486911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Arterial hypertension, left ventricular hypertrophy and arrhythmias].
    González Maqueda I
    Rev Esp Cardiol; 1991 Nov; 44(9):586-98. PubMed ID: 1723211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cardiac risks of hypokalemia and hypomagnesemia].
    Krämer BK; Endemann D
    Ther Umsch; 2000 Jun; 57(6):398-9. PubMed ID: 10894026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential mechanisms explaining the risk of left ventricular hypertrophy.
    Frohlich ED
    Am J Cardiol; 1987 Jan; 59(2):91A-97A. PubMed ID: 2949582
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of ventricular arrhythmias in cardiac hypertrophy.
    McLenachan JM; Dargie HJ
    J Cardiovasc Pharmacol; 1991; 17 Suppl 2():S46-9. PubMed ID: 1715485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypertensive heart disease--significance of left ventricular hypertrophy.
    Schmieder RE
    J Cardiovasc Pharmacol; 1992; 20 Suppl 6():S50-5. PubMed ID: 1283190
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].
    Franchi F; Michelucci A; Padeletti L; Monopoli A; Fabbri G; Cersosimo RM; Mezzani A
    G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current drug treatment and treatment patterns with antihypertensive drugs.
    Freis ED; Papademetriou V
    Drugs; 1996 Jul; 52(1):1-16. PubMed ID: 8799681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of sudden cardiac death in never previously treated patients with essential hypertension: long-term follow-up.
    Saadeh AM; Jones JV
    J Hum Hypertens; 2001 Oct; 15(10):677-80. PubMed ID: 11607796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidence of sudden cardiac death associated with coronary artery occlusion in dogs with hypertension and left ventricular hypertrophy is reduced by chronic beta-adrenergic blockade.
    Dellsperger KC; Martins JB; Clothier JL; Marcus ML
    Circulation; 1990 Sep; 82(3):941-50. PubMed ID: 1975521
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy.
    McLenachan JM; Henderson E; Morris KI; Dargie HJ
    N Engl J Med; 1987 Sep; 317(13):787-92. PubMed ID: 2957590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antihypertensive treatment and left ventricular hypertrophy].
    Agabiti-Rosei E; Muiesan ML; Rizzoni D
    Ann Ital Med Int; 1993 Oct; 8 Suppl():97S-103S. PubMed ID: 8117529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of antihypertensive therapy on hypertensive heart disease.
    Messerli FH; Kaesser UR; Losem CJ
    Circulation; 1989 Dec; 80(6 Suppl):IV145-50. PubMed ID: 2532079
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of diuretic therapy on ventricular arrhythmias in hypertensive patients with or without left ventricular hypertrophy.
    Papademetriou V; Price M; Notargiacomo A; Gottdiener J; Fletcher RD; Freis ED
    Am Heart J; 1985 Sep; 110(3):595-9. PubMed ID: 2412429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study.
    Wachtell K; Gerdts E; Aurigemma GP; Boman K; Dahlöf B; Nieminen MS; Olsen MH; Okin PM; Palmieri V; Rokkedal JE; Devereux RB
    Blood Press; 2010 Jun; 19(3):169-75. PubMed ID: 20438307
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electrolyte disarray and cardiovascular disease.
    Hollifield JW
    Am J Cardiol; 1989 Jan; 63(4):21B-26B. PubMed ID: 2643289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The paradoxical role of left ventricular hypertrophy in wall stress-related arrhythmia.
    James MA; Jones JV
    J Hypertens; 1992 Feb; 10(2):167-72. PubMed ID: 1313480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Impact of arterial hypertension on the heart].
    Herpin D
    Rev Prat; 1999 Mar; 49(5):491-4. PubMed ID: 10358398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.